Infectious Diseases Diagnostics Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
RESEARCH REPORT<br />
NOVEMBER 2017<br />
INFECTIOUS DISEASES DIAGNOSTICS MARKET<br />
SEGMENTED BY PRODUCT, APPLICATION, TECHNOLOGY, END-<br />
USER AND REGION-INDUSTRY ANALYSIS, SIZE, SHARE, GROWTH,<br />
TRENDS AND FORECASTS 2016-2021
<strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> Size is anticipated to grow at a 7.90% CAGR from<br />
2016 to 2021 and it is estimated that the global market was valued at USD 14.45 billion in<br />
2016 and is relied upon to achieve USD 21.13 billion by 2021. <strong>Infectious</strong> disease diagnostics<br />
involves various methods to check for the presence of foreign antigen/organism with the<br />
help of numerous diagnostic tools. <strong>Infectious</strong> disease conditions are highly widespread in<br />
under developed regions owing to the lack of awareness for personal hygiene, minimal<br />
health care expenditures, and absence of efficient physician services. Rising cases of<br />
infectious diseases in developed economies is further expected to boost the market growth.<br />
This has lead vitro diagnostic device manufacturers to invest into emerging economies.<br />
These companies are taking efforts to develop and commercialize cost effective tools for the<br />
infectious disease diagnosis.<br />
Disease diagnostics are used for confirmation of a disease in form of a quick, precise test<br />
result. Being time consuming, disease diagnostics are on a rise. The infectious disease<br />
epidemics are spreading worldwide, thereby leading to an increase in demand of diagnostic<br />
tests. In addition, the incidences of malaria, flu, AIDS, and other diseases are also on a rise,<br />
creating a robust demand for infectious disease diagnostics. With a majority of physicians<br />
adopting the evidence-based treatment method, infectious disease diagnostic kits are more<br />
likely to gain traction over the forecast period. Several government-funded programs all<br />
over the globe are increasingly providing free screening and tests in order to increase<br />
awareness, accurately diagnose diseases, and minimize the chances of infection. Such<br />
initiatives are anticipated to boost the market growth in the next few years. However,<br />
diagnostic kits are expensive and manufacturers still have a poor distribution channel for<br />
operating across emerging economies. These two factors are projected to be the key<br />
challenges to rapid revenue growth of the global infectious diseases diagnostics market.<br />
<strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> Segmentation by Product, Application, Technology<br />
and End User. On the basis of Product, it is segmented into Instruments, Reagents, Services,<br />
and Software. Consumables accounted for the largest share. On the basis of Application, it is<br />
segmented into Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis<br />
(TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus<br />
(HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola,<br />
Typhoid, Malaria, and Dengue) included. Hospital-acquired MRSA infections and human<br />
papillomavirus (HPV) are expected to be the fastest-growing market segments in the<br />
forecast period. On the basis of technology, it is segmented into PCR, INAAT, DNA<br />
Sequencing and Hybridization. Traditional methods are categorized into immunodiagnostics,<br />
microscopy, and biochemical characterization. Microarrays and INAAT are projected to<br />
witness the highest growth during the forecast period. This noteworthy growth can be<br />
accredited to the specificity and an increase in the efficiency of these tests. On the basis of<br />
End User, it is segmented into Hospital and Laboratories. Hospital laboratories and<br />
reference labs held the largest share in this market segment.<br />
<strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> geographical segmentation by North America,<br />
Europe, Asia-Pacific and Middle East and Africa. North America held the largest share of the
IDD market, followed by Europe. Both regions are projected to witness single-digit growth<br />
rates during the coming years. Be that as it may, Asia-Pacific is projected to register the<br />
highest growth rate in the coming years, due to the high pervasiveness of infectious<br />
diseases, and huge investment opportunities due to a growth in healthcare expenditure.<br />
<strong>Market</strong> Segmentation:<br />
1 Product<br />
1.1 Introduction<br />
1.2 Instruments & Analyzers<br />
1.3 Consumables<br />
1.3.1 Assays and Reagents<br />
1.4 Services & Softwares<br />
1.5 Y-o-Y Growth Analysis, By Product<br />
1.6 <strong>Market</strong> Attractiveness Analysis, By Product<br />
1.7 <strong>Market</strong> Share Analysis, By Product<br />
2 Techniques<br />
2.1 Introduction<br />
2.2 Traditional Diagnostic Techniques<br />
2.2.1 Immunodiagnostics<br />
2.2.2 Microscopy<br />
2.2.3 Biochemical Characterization<br />
2.3 Molecular <strong>Diagnostics</strong><br />
2.3.1 PCR<br />
2.3.2 INAAT<br />
2.3.2 Hybridization<br />
2.3.3 DNA Sequencing & NGS<br />
2.3.4 Microarray<br />
2.3.5 Others<br />
2.4 Y-o-Y Growth Analysis, By Technique<br />
2.5 <strong>Market</strong> Attractiveness Analysis, By Technique<br />
2.6 <strong>Market</strong> Share Analysis, By Technique
3 Applications<br />
3.1 Introduction<br />
3.2 Hepatitis B<br />
3.3 Hepatitis C<br />
3.4 Human Immunodeficiency Virus (HIV)<br />
3.5 Tuberculosis (TB)<br />
3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)<br />
3.7 Human papillomavirus (HPV)<br />
3.8 Methicillin-resistant Staphylococcus aureus (MRSA)<br />
3.9 Others<br />
3.10 Y-o-Y Growth Analysis, By Application<br />
3.11 <strong>Market</strong> Attractiveness Analysis, By Application<br />
3.12 <strong>Market</strong> Share Analysis, By Application<br />
4 End User<br />
4.1 Introduction<br />
4.2 Hospitals Laboratories<br />
4.3 Physician office Labs<br />
4.4 Academics<br />
4.5 Others<br />
The major <strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> leaders are Abbott Laboratories,<br />
bioMérieux SA, Hologic, Inc., Danaher Corporation, SBecton, Dickinson and Company,<br />
Cepheid, Inc., Thermo Fisher Scientific Inc., Roche <strong>Diagnostics</strong>, Alere Inc., DiaSorin S.p.A.,<br />
Quidel Corporation, and Bio-Rad Laboratories, Inc.<br />
TABLE OF CONTENTS<br />
1. Introduction<br />
1.1 <strong>Market</strong> Definition<br />
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods<br />
1.4 General Study Assumptions<br />
2. Research Methodology<br />
2.1 Introduction<br />
2.2 Research Phases<br />
2.2.1 Secondary Research<br />
2.2.2 Primary Research<br />
2.2.3 Econometric Modelling<br />
2.2.4 Expert Validation<br />
View Report at http://www.marketdataforecast.com/market-reports/infectious-diseasesdiagnostics-market-4607/<br />
2.3 Analysis Design<br />
2.4 Study Timeline<br />
3. Overview<br />
3.1 Executive Summary<br />
3.2 Key Inferences<br />
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />
4.1 <strong>Market</strong> Drivers<br />
4.2 <strong>Market</strong> Restraints<br />
4.3 Key Challenges<br />
4.4 Current Opportunities in the <strong>Market</strong>
Get free sample report at http://www.marketdataforecast.com/market-reports/infectiousdiseases-diagnostics-market-4607/request-sample<br />
5. <strong>Market</strong> Segmentation<br />
5.1 Product<br />
5.1.1 Introduction<br />
5.1.2 Instruments & Analyzers<br />
5.1.3 Consumables<br />
5.1.3.1 Assays and Reagents<br />
5.1.4 Services & Softwares<br />
5.1.5 Y-o-Y Growth Analysis, By Product<br />
5.1.6 <strong>Market</strong> Attractiveness Analysis, By Product<br />
5.1.7 <strong>Market</strong> Share Analysis, By Product<br />
5.2 Technique<br />
5.2.1 Introduction<br />
5.2.2 Traditional Diagnostic Techniques<br />
5.2.2.1 Immunodiagnostics<br />
5.2.2.2 Microscopy<br />
5.2.2.3 Biochemical Characterization<br />
5.2.3 Molecular <strong>Diagnostics</strong><br />
5.2.3.1 PCR<br />
5.2.3.2 INAAT<br />
5.2.3.2 Hybridization<br />
5.2.3.3 DNA Sequencing & NGS<br />
5.2.3.4 Microarray<br />
5.2.3.5 Others<br />
5.2.4 Y-o-Y Growth Analysis, By Technique<br />
5.2.5 <strong>Market</strong> Attractiveness Analysis, By Technique<br />
5.2.6 <strong>Market</strong> Share Analysis, By Technique
Request Customization at http://www.marketdataforecast.com/marketreports/infectious-diseases-diagnostics-market-4607/customize-report<br />
5.3 Application<br />
5.3.1 Introduction<br />
5.3.2 Hepatitis B<br />
5.3.3 Hepatitis C<br />
5.3.4 Human Immunodeficiency Virus (HIV)<br />
5.3.5 Tuberculosis (TB)<br />
5.3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)<br />
5.3.7 Human papillomavirus (HPV)<br />
5.3.8 Methicillin-resistant Staphylococcus aureus (MRSA)<br />
5.3.9 Others<br />
5.3.10 Y-o-Y Growth Analysis, By Application<br />
5.3.11 <strong>Market</strong> Attractiveness Analysis, By Application<br />
5.3.12 <strong>Market</strong> Share Analysis, By Application<br />
5.4 End User<br />
5.4.1 Introduction<br />
5.4.2 Hospitals Laboratories<br />
5.4.3 Physician office Labs<br />
5.4.4 Academics<br />
5.4.5 Others<br />
5.4.6 Y-o-Y Growth Analysis, By End User<br />
5.4.7 <strong>Market</strong> Attractiveness Analysis, By End User<br />
5.4.8 <strong>Market</strong> Share Analysis, By End User<br />
Enquire before buying at http://www.marketdataforecast.com/market-reports/infectiousdiseases-diagnostics-market-4607/inquire<br />
6. Geographical Analysis
6.1 North America<br />
6.2 Europe<br />
6.1.1 Introduction<br />
6.1.2 United States<br />
6.1.3 Canada<br />
6.2.1 Introduction<br />
6.2.2 U.K<br />
6.2.3 Spain<br />
6.2.4 Germany<br />
6.2.5 Italy<br />
6.2.6 France<br />
Buy this report at http://www.marketdataforecast.com/cart/buy-now/infectious-diseasesdiagnostics-market-4607<br />
6.3 Asia-Pacific<br />
6.3.1 Introduction<br />
6.3.2 China<br />
6.3.3 India<br />
6.3.4 Japan<br />
6.4 Latin America<br />
6.4.1 Introduction<br />
6.4.2 Brazil<br />
6.4.3 Argentina
6.4.4 Mexico<br />
6.5 Middle East & Africa<br />
6.5.1 Introduction<br />
6.5.2 Middle-East<br />
6.5.3 Africa<br />
7. Strategic Analysis<br />
7.1 PESTLE analysis<br />
7.1.1 Political<br />
7.1.2 Economic<br />
7.1.3 Social<br />
7.1.4 Technological<br />
7.1.5 Legal<br />
7.1.6 Environmental<br />
7.2 Porter’s Five analysis<br />
7.2.1 Bargaining Power of Suppliers<br />
7.2.2 Bargaining Power of Consumers<br />
7.2.3 Threat of New Entrants<br />
7.2.4 Threat of Substitute Products and Services<br />
7.2.5 Competitive Rivalry within the Industry<br />
8. <strong>Market</strong> Leaders' Analysis<br />
8.1 Abbott Laboratories<br />
8.1.1 Overview
8.1.2 Product Analysis<br />
8.1.3 Financial analysis<br />
8.1.4 Recent Developments<br />
8.1.5 SWOT analysis<br />
8.1.6 Analyst View<br />
8.2 bioMérieux SA<br />
8.3 Hologic Inc.<br />
8.4 Danaher Corporation<br />
8.5 Sbecton<br />
8.6 Dickinson and Company<br />
8.7 Cepheid Inc.<br />
8.8 Thermo Fisher Scientific Inc.<br />
8.9 Roche <strong>Diagnostics</strong><br />
8.10 Alere Inc.<br />
9. Competitive Landscape<br />
9.1 <strong>Market</strong> share analysis<br />
9.2 Merger and Acquisition Analysis<br />
9.3 Agreements, collaborations and Joint Ventures<br />
9.4 New Product Launches<br />
10. <strong>Market</strong> Outlook and Investment Opportunities<br />
Appendix<br />
a) List of Tables
) List of Figures<br />
For more related reports from Healthcare IT segment:<br />
A. Genomics <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/global-genomicsmarket-2610/<br />
B. Medical Tourism <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/globalmedical-tourism-market-1855/<br />
C. Transcatheter Aortic Valve Replacement (TAVR) <strong>Market</strong>:<br />
http://www.marketdataforecast.com/market-reports/transcatheter-aortic-valvereplacement-market-357/<br />
D. Empty Capsules <strong>Market</strong>: http://www.marketdataforecast.com/marketreports/global-empty-capsules-market-439/<br />
SCOPE OF THE REPORT<br />
<br />
<br />
<br />
<br />
<br />
Global, regional and country-level analysis and forecasts of the study market;<br />
providing Insights on the major countries/regions in which this industry is blooming<br />
and to also identify the regions that are still untapped<br />
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />
market and their impact on shifting market dynamics<br />
Study of the effect of exogenous and endogenous factors that affect the global<br />
market; which includes broadly demographic, economics, and political, among other<br />
macro-environmental factors presented in an extensive PESTLE Analysis<br />
Study the micro environment factors that determine the overall profitability of an<br />
Industry, using Porter’s five forces analysis for analyzing the level of competition<br />
and business strategy development<br />
A comprehensive list of key market players along with their product portfolio,<br />
current strategic interests, key financial information, legal issues, SWOT analysis and<br />
analyst overview to study and sustain the market environment
An executive summary, abridging the entire report in such a way that decisionmaking<br />
personnel can rapidly become acquainted with background information,<br />
concise analysis and main conclusions<br />
ABOUT US<br />
<strong>Market</strong> Data Forecast is a firm working in the areas of market<br />
research and business intelligence. We have rich experience in<br />
research across various business domains and we cater to the needs<br />
of both individual and corporate clients. Our research services assist<br />
clients in key business areas like business process improvement, key<br />
decision making and developing appropriate corporate strategy. We<br />
are truly committed to our clients and other stakeholders for<br />
providing customized research services of the highest quality.<br />
CONTACT INFORMATION<br />
We always look forward to working with new clients, pushing our<br />
boundaries and extending our reach beyond global horizons. Get in<br />
touch with us for further queries.<br />
Website: www.marketdataforecast.com<br />
E-Mail: contact@marketdataforecast.com<br />
Phone: +1 888-702-9626 (U.S Toll free),<br />
+91 7680952236 (Indian Office).<br />
FOR MORE INFORMATION